Uremia
Recent clinical, regulatory, research and industry developments relating to this disease.
Mechanisms of cognitive dysfunction in CKD.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes6
- Gastrointestinal Microbiome2
- Dysbiosis1
- Kidney1
- Metabolome1
- Nutrition Therapy1
- Renal Insufficiency, Chronic1
Leading journals3
- Gut1
- Nature reviews. Nephrology1
- Nutrients1
Leading researchers8
- Bian W1
- Capasso G1
- Chen S1
- Cui W1
- Ehrlich SD1
- Gao X1
- Gu Z1
- Guo H1
Affiliations (unnormalised)6
- Aerospace Center Hospital1
- Beijing Advanced Innovation Center for Food Nutrition and Human Health1
- Beijing AnZhen Hospital1
- Beijing Laboratory of Food Quality and Safety1
- Cornell University1
- Dental Institute1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.